OK-JIN PARK

Dr. OK-JIN PARK

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
OPOK-JIN PARK
OK-JIN PARK
YKYeongkag Kwon
Yeongkag Kwon
CPChaeyeon Park
Chaeyeon Park
YSYoon Ju So
Yoon Ju So
TPTae Hwan Park
Tae Hwan Park
SHSeung Hyun Han
Seung Hyun Han
Streptococcus gordonii, a Gram-positive bacterium, is a commensal bacterium that is commonly found in the skin, oral cavity, and intestine. It is also known as an opportunistic pathogen that can cause local or systemic diseases, such as apical periodontitis and infective endocarditis. S. gordonii, an early colonizer, easily attaches to host tissues, including tooth surfaces and heart valves, forming biofilms. S. gordonii penetrates into root canals and blood streams, subsequently interacting with various host immune and non-immune cells. The cell wall components of S. gordonii, which include lipoteichoic acids, lipoproteins, serine-rich repeat adhesins, peptidoglycans, and cell wall proteins, are recognizable by individual host receptors. They are involved in virulence and immunoregulatory processes causing host inflammatory responses. Therefore, S.gordonii cell wall components act as virulence factors that often progressively develop diseases through overwhelming host responses. This review provides an overview of S. gordonii, and how its cell wall components could contribute to the pathogenesis and development of therapeutic strategies.

1 March 2019 in Journal of Endodontics
Verified
Journal Article
Closed access
AKA Reum Kim
A Reum Kim
KAKi Bum Ahn
Ki Bum Ahn
CYCheol-Heui Yun
Cheol-Heui Yun
OPOK-JIN PARK
OK-JIN PARK
HPHiran Perinpanayagam
Hiran Perinpanayagam
SHSeung Hyun Han
Seung Hyun Han

Verified
Journal Article
Open access
PDF file
YKYeongkag Kwon
Yeongkag Kwon
CPChaeyeon Park
Chaeyeon Park
JLJueun Lee
Jueun Lee
DPDong Hyun Park
Dong Hyun Park
SJSungho Jeong
Sungho Jeong
SHSeung Hyun Han
Seung Hyun Han
Gut microbiota has emerged as an important regulator of bone homeostasis. In particular, the modulation of innate immunity and bone homeostasis is mediated through the interaction between microbe-associated molecular patterns (MAMPs) and the host pattern recognition receptors including Toll-like receptors and nucleotide-binding oligomerization domains. Pathogenic bacteria such as Porphyromonas gingivalis and Staphylococcus aureus tend to induce bone destruction and cause various inflammatory bone diseases including periodontal diseases, osteomyelitis, and septic arthritis. On the other hand, probiotic bacteria such as Lactobacillus and Bifidobacterium species can prevent bone loss. In addition, bacterial metabolites and various secretory molecules such as short chain fatty acids and cyclic nucleotides can also affect bone homeostasis. This review focuses on the regulation of osteoclast and osteoblast by MAMPs including cell wall components and secretory microbial molecules under in vitro and in vivo conditions. MAMPs could be used as potential molecular targets for treating bone-related diseases such as osteoporosis and periodontal diseases.

19 February 2019 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
YKYeongkag Kwon
Yeongkag Kwon
OPOK-JIN PARK
OK-JIN PARK
JKJiseon Kim
Jiseon Kim
JCJae-Ho Cho
Jae-Ho Cho
CYCheol-Heui YUN
Cheol-Heui YUN
SHSeung Hyun Han
Seung Hyun Han
Cyclic dinucleotides (CDNs) such as cyclic diadenylate monophosphate and cyclic diguanylate monophosphate are commensal bacteria‐derived second messengers in the gut that modulate bacterial survival, colonization, and biofilm formation. Recently, CDNs have been discovered to have an immunomodulatory activity by inducing the expression of type I interferon (IFN) through STING signaling pathway in macrophages. Since CDNs are possibly absorbed and delivered into the bone marrow, where bone‐resorbing osteoclasts are derived from monocyte/macrophage lineages, CDNs could affect bone metabolism by regulating osteoclast differentiation. In this study, we investigated the effect of CDNs on the differentiation and function of osteoclasts and osteoblasts. When bone marrow‐derived macrophages (BMMs) were differentiated into osteoclasts with M‐CSF and RANKL in the presence of CDNs, the differentiation was inhibited by CDNs in a dose‐dependent manner. In contrast, CDNs did not influence the differentiation of committed osteoclasts or osteoblast precursors. STING signaling pathway appeared to be critical for CDNs‐mediated inhibition of osteoclast differentiation since CDNs induced the phosphorylation of TBK1 and IRF3, a representative feature of STING activation, and osteoclast differentiation was restored in STING knockdown BMMs with siRNA. Moreover, CDNs increased the mRNA expression of STING‐meditated IFN‐β, which is a negative regulator of osteoclastogenesis. In addition, CDNs also induced the phosphorylation of STAT1, which mediates IFN‐α/β receptor (IFNAR) signal transduction. The inhibitory effects of CDNs on osteoclast differentiation were not observed in the presence of antibody blocking IFNAR or in macrophages derived from IFNAR1‐/‐ mice. Experiments using a mouse calvarial implantation model showed that RANKL‐induced bone resorption was inhibited by CDNs. Taken together, these results suggest that CDNs inhibit osteoclast differentiation and bone resorption through induction of IFN‐β via the STING signaling pathway. This article is protected by copyright. All rights reserved

28 October 2019 in Journal of Microbiology
Verified
Journal Article
Closed access
PDF file
SJSoyoung Jeong
Soyoung Jeong
YLYunjae Lee
Yunjae Lee
CYCheol-Heui YUN
Cheol-Heui YUN
OPOK-JIN PARK
OK-JIN PARK
SHSeung Hyun Han
Seung Hyun Han
Enterococci are Gram-positive facultative anaerobic bacteria that colonize the oral cavity and gastrointestinal tract. Enterococcal infections, mainly caused by Enterococcus faecalis and Enterococcus faecium, include apical periodontitis, endocarditis, and bloodstream infections. Recently, vancomycinresistant Enterococci are considered major pathogens that are common but difficult to treat, especially in nosocomial settings. Moreover, E. faecalis is closely associated with recurrent endodontic infections and failed endodontic treatment. In this study, we investigated the effects of short-chain fatty acids (SCFAs), acetate, propionate, and butyrate, which are metabolites fermented by gut microbiota, on the growth of Enterococci. Enterococci were cultured in the presence or absence of acetate, propionate, or butyrate, and the optical density at 600 nm was measured to determine bacterial growth. The minimum inhibitory concentration/minimum bactericidal concentration test was conducted. Bacteria were treated with a SCFA, together with clinically used endodontic treatment methods such as triple antibiotics (metronidazole, minocycline, and ciprofloxacin) and chlorhexidine gluconate (CHX) to determine the effects of combination treatment. Of the SCFAs, propionate had a bacteriostatic effect, inhibiting the growth of E. faecalis in a dose-dependent manner and also that of clinical strains of E. faecalis isolated from dental plaques. Meanwhile, acetate and butyrate had minimal effects on E. faecalis growth. Moreover, propionate inhibited the growth of other Enterococci including E. faecium. In addition, combination treatment of propionate and triple antibiotics led to further growth inhibition, whereas no cooperative effect was observed at propionate plus CHX. These results indicate that propionate attenuates the growth of Enterococci, suggesting propionate as a potential agent to control Enterococcal infections, especially when combined with triple antibiotics.